摘要
目的探讨疏血通注射液治疗急性脑梗死的疗效。方法将86例急性脑梗死患者随机分为对照组(43例)和治疗组(43例)。对照组给予常规降颅压、促脑细胞功能恢复、抗血小板聚集治疗,治疗组在对照组治疗方法的基础上加用疏血通注射液静滴。治疗两周后,比较两组患者神经功能缺损程度、D-二聚体、血液黏稠度、超敏C反应蛋白、特异性烯醇化酶水平变化。结果治疗两周后,治疗组神经功能明显改善,血粘度、D-二聚体、超敏C反应蛋白、特异性烯醇化酶水平明显低于对照组(P<0.05);治疗组总有效率为97.67%,明显高于对照组的86.05%(P<0.05)。结论疏血通注射液能有效缓解脑梗死急性加重期患者的病情,改善患者症状。
Objective To explore the curative effect of Shuxuetong injection in the treatment of acute cerebral infarction. Methods Eighty-six cases of patients with acute cerebral infarction were randomly divided into control group (43 cases) and treatment group (43 cases). The control group was given conventional intraeranial pressure reduction, brain cell function recovery and antiplatelet therapy, the treatment group added Shuxuetong injection on the basis of the control group. After two weeks, the levels of neurological deficits, D-dimer, blood viscosity, high-sensitivity C-reactive protein and specific enolase were compared between the two groups. Results After two weeks, the neurological function of the treatment group was improved obviously, and the levels of blood viscosity, D-dimer, C-reactive protein and specific enolase in the treatment group were significantly lower than those in the control group (P〈0.05). The effective rate of the treatment group was 97.67%, which was significantly higher than 86.05% of the control group (P〈0.05). Conclusion Shuxuetong injection can effectively alleviate the disease for patients with cerebral infarction during acute exacerbation and improve the patient's symptoms.
出处
《临床医学研究与实践》
2017年第1期36-37,共2页
Clinical Research and Practice